Inogen adds Tom West to board
By HME News Staff
Updated 10:10 AM CDT, Mon March 27, 2023
GOLETA, Calif. – Inogen has named Tom West to its board of directors effective April 1. “We are pleased to welcome Tom West to the Inogen board,” said Elizabeth Mora, who chairs the board. “Tom brings additional general management and operational experience to the Inogen board with his history of leadership and business success in medical technology and life sciences health care spaces.” West serves as president and CEO, as well as executive director of the board, of Nalu Medical, a medtech company focused on neurostimulation to treat chronic intractable pain. Before Nalu, he served as president, CEO and director at Intersect ENT, which was acquired by Medtronic in May of 2022. West served as an independent member of the board of directors of the public traded company Orthofix from 2021 to 2023. “I am thrilled to have the opportunity to advance Inogen’s transformation into a global respiratory care leader,” said West, who will join the Compliance Committee and the Governance Committee of the board. “Inogen has been an industry innovator. I look forward to adding my operating experience accelerating growth opportunities to help the company enhance the value it delivers to its patients, customers and shareholders.” Inogen also announced that Kristen Miranda will retire from the board effective March 31.
Comments